Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...

Abstract:        Obesity, a growing global issue, has been closely associated with an increased risk of various cancers, especially breast cancer. El ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and ...

Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...

Combining two FDA-approved cancer drugs trametinib and rapamycin increases the lifespan of mice by an amazing 30%, according ...